What's new in vascular infections?

Current Surgery

Volumn 56, Issue 6, 1999, Pages 335-340

  Dahn, Michael S ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033164361     PISSN: 01497944     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7944(99)00096-3     Document Type: Article

References (51)

1. O'Brien T, Collin J. Prosthetic vascular graft infection. Br J Surg 1992; 79:1262-1267.
2. Strachan CJ. The prevention of orthopedic implant and vascular graft infections. J Hosp Infect 1995; 30(suppl):54-63.
3. Hall JC, Christiansen KJ, Goodman M, et al. Duration of antimicrobial prophylaxis in vascular surgery. Am J Surg 1998; 175:87-90.
4. Hicks RCJ, Greenhalgh RM. The pathogenesis of vascular graft infection. Eur J Vasc Endovasc Surg 1997; 14(suppl A):5-9.
5. Kikta MJ, Goodman LJ, Bishara RA. Mortality and limb loss with infected infrainguinal bypass grafts. J Vasc Surg 1987; 5:566-571.
6. Schmitt DD. Antibiotic usage in the prevention and treatment of graft infection. Sem Vasc Surg 1990; 3:133-40.
7. Page CO, Bohnen JMA, Fletcher R, et al. Antimicrobial prophylaxis for surgical wounds. Guidelines for Clinical Care. Arch Surg 1993; 128:79-88.
8. Kaiser AB, Clayson DR, Mulherin JL, et al. Antibiotic prophylaxis in vascular surgery. Ann Surg 1978; 188:283-289.
9. Pitt HA, Postier RG, MacGowan WAL, et al. Prophylactic antibiotic in vascular surgery: topical, systemic, or both? Ann Surg 1980; 192: 356-364.
10. Antimicrobial prophylaxis. Med Lett Drugs Ther 1997; 39:97-101.
11. Hasselgren PO, Ivarsson L, Risberg B, et al. Effects of prophylactic antibiotics in vascular surgery. A prospective, randomized, double-blind study. Ann Surg 1984; 200:86-92.
12. Hopkins CC. Antibiotic prophylaxis in clean surgery: peripheral vascular surgery, noncardiovascular thoracic surgery, herniorrhaphy and mastectomy. Rev Infect Dis 1991; 13(suppl 10):S869-S873.
13. Zengaffinen R, Lange J. Cost due to incorrect antibiotic prophylaxis in visceral, thoracic and vascular surgery. Swiss Surg 1997; 3:125-128.
14. Cox TR. Vascular infections: exceeding the threshold. Milit Med 1995; 160:609-611.
15. Landrenean MD, Raju S. Infections after elective bypass surgery for lower limb ischemia: the influence of preoperative transcutaneous arteriography. Surgery 1981; 90:956-961.
16. Millward SF, Peterson RA, Moher D, et al. LGM (Vena Tech) Vena caval filter: experience at a single institution. JVIR 1994; 5:351-356.
17. Deiparine MK, Ballard JL, Taylor FC, et al. Endovascular stent infection. J Vasc Surg 1996; 23:529-533.
18. Weinberg DJ, Cronin DW, Baker AG. Infected iliac pseudoaneurysm after uncomplicated percutaneous balloon angioplasty and (Palmaz) stent insertion: a case report and literature review. J Vasc Surg 1996; 23:162-166.
19. Bunt TJ, Gill HK, Smith DC, et al. Infection of a chronically implanted iliac artery stent. Ann Vasc Surg 1997; 11:529-532.
20. Dravid VS, Gupta A, Zegal AV, et al. Investigation of antibiotic prophylaxis usage for vascular and non-vascular interventional procedures. JVIR 1998; 9:401-406.
21. McDermott VG, Schuster MG, Smith TP. Antibiotic prophylaxis in vascular and interventional radiology. AJR 1997; 169:31-38.
22. Gelabert HA, Colburn MD. Development and results of antibiotic impregnated vascular grafts. In: Moore WS, Gelabert HA, editors. Antibiotic-impregnated vascular grafts. Austin: Landes; Boca Raton: CRC, 1992:88-100.
23. Malone JM, Moore WS, Compagna G, et al. Bacteremic infectability of vascular grafts: the influence of pseudointimal integrity and duration of graft function. Surgery 1975; 78:211-216.
24. Chervu A, Moore WS, Gelabert HA, et al. Prevention of graft infection by use of prosthesis bonded with a rifampin/collagen release system. J Vasc Surg 1991; 14:521-525.
25. McDougal EG, Burnham SJ, Johnson GL. Rifampin protection against experimental graft sepsis. J Vasc Surg 1986; 4:5-7.
26. Haverich A, Hirt S, Karek M, et al. Prevention of graft infection by bonding of gentamicin to dacron prostheses. J Vasc Surg 1992; 15: 187-193.
27. Clark RE, Margraf HW. Antibacterial vascular grafts with improved thromboresistance. Arch Surg 1974; 109:159-162.
28. Greco RS, Harvey RA, Smilow PC, et al. Prevention of vascular prosthetic infection by benzalkonium-oxacillin bonded polytetrafluoroethylene graft. Surg Gynecol Obstet 1982; 155:28-32.
29. Shue WB, Worosilo SC, Donetz AP, et al. Prevention of vascular prosthetic infections with an antibiotic-bonded dacron graft. J Vasc Surg 1988; 8:600-605.
30. Shenk JS, Ney AL, Tsukayama DE, et al. Tobramycin-adhesive in preventing and treating PTFE vascular graft infections. J Surg Res 1989; 47:487-492.
31. Sobinsky KR, Flanigan DP. Antibiotic binding to polytetrafluroethylene via glucosominoglycan-keratin luminal coating. Surgery 1986; 100:629-634.
32. Avramovic J, Fletcher JP. Prevention of prosthetic vascular graft infection by rifampin impregnation of a protein-sealed dacron graft in combination with parenteral cephalosporin. J Cardiovasc Surg 1992; 33:70-74.
33. Kinney EV, Bandyk DF, Seabrook GA, et al. Antibiotic-bonded PTFE vascular grafts: the effect of silver antibiotic on bioactivity following implantation. J Surg Res 1991; 50:430-435.
34. Greco RS, Harvey RA. Therapeutic strategies based on antibiotic bonding. In: Bunt TJ, editor. Vascular graft infections. Armonk: Futura, 1994:125-138.
35. D'Addato M, Curti T, Freyrie A. The rifampicin-bonded gelseal graft. Eur J Vasc Endovasc Surg 1997; 14(suppl A):15-17.
36. Torsello G, Sandman W, Gehrt A, et al. In situ replacement of infected vascular prosthesis with rifampin-soaked vascular grafts: early results. J Vasc Surg 1993; 17:768-773.
37. 37. Semba CP, Sakai T, Slonim S, et al. Mycotic aneurysms of the thoracic aorta. Repair with use of endovascular stend-grafts. JVIR 1998; 9:33-40. PTFE vascular grafts: the effect of silver antibiotic on bioactivity following implantation. J Surg Res 1991; 50:430-435.
38. Semba CP, Sakai T, Slonim S, et al. Mycotic aneurysms of the thoracic aorta. Repair with use of endovascular stend-grafts. JVIR 1998; 9:33-40. PTFE vascular grafts: the effect of silver antibiotic on bioactivity following implantation. J Surg Res 1991; 50:430-435.
39. Reily IM, Stoney RT, Goldstone J, et al. Improved management of aortic graft infection: the influence of operations sequence and staging. J Vasc Surg 1987; 5:421-431.
40. Ricotta JT, Faggioli GL, Stella A, et al. Total excision and extra-anatomic bypass for aortic graft infection. Am J Surg 1991; 162:145-149.
41. Trout HH, Kozhoff L, Giordona JM. Priority of revascularization in patient with graft enteric fistulas, infected arteries or infected arterial prosthesis. Ann Surg 1984; 199:669-683.
42. Wilker WE, Coolege DA, Duncan JM, et al. The management of aortoduodenal fistula by in situ replacement of the infected abdominal aortic graft. Ann Surg 1987; 205:727-732.
43. Ehrenfeld WK, Wilbur BG, Olcott CN, et al. Autogenous tissue reconstruction in the management of infected prosthetic grafts. Surgery 1979; 85:82-92.
44. Bandyk DP, Bergamini TM, Kinney EV, et al. In situ replacement of vascular prostheses infected by bacterial biofilms. J Vasc Surg 1991; 13:575-583.
45. Clagett GP, Bowers BL, Lopex-Viegro MA, et al. Creation of a neo-aortoiliac system from lower extremity deep and superficial veins. Ann Surg 1997; 218:239-249.
46. Nevelsteen A, Lacroix H, Suy R. Autogenous reconstruction with the lower extremity deep veins: an alternative treatment of prosthetic infection after reconstructive surgery for aortoiliac disease. J Vasc Surg 1995; 22:129-134.
47. Wells JK, Hagino RT, Bargmann KM, et al. Venous morbidity after superficial femoral popliteal vein harvest. J Vasc Surg 1999; 29:282-291.
48. Nevelsten A, Lacroix H, Suy R. Infrarenal aortic graft infection: in situ aortoiliofemoral reconstruction with the lower extremity deep veins. Eur J Vasc Endovasc Surg 1997; 14(suppl A):88-92.
49. Ruotolo C, Plissonier D, Bahnini A, et al. In situ arterial allografts: a new treatment for aortic prosthetic infection. Eur J Vasc Endovasc Surg 14(suppl A):1997; 102-107.
50. Kieffer E, Bahnini A, Koskas F, et al. In situ allograft replacement of infected infrarenal aortic prosthetic grafts; results in forty-three patients. J Vasc Surg 1993; 17:349-356.
51. Knosalla C, Goeau-Brissonniere O, Leflon V, et al. Treatment of vascular graft infection by in situ replacement with cryopreserved aortic allografts: an experimental study. J Vasc Surg 1998; 27:689-698.